News

"Employers are focusing on recalibrating more than cutting and are continuing to invest in care benefits even as they trim other costs," Care.com reports.

Just days after the other two drugmakers dropped their prices, Sanofi is capping the cost of its most prescribed insulin at $35 for the privately insured, as a price gouging lawsuit against all three drugmakers gets underway.

Under mounting pressure, Novo Nordisk plans to cut list prices for insulin products by up to 75%, now the latest drugmaker to take such a step following a California lawsuit accusing drugmakers of driving up costs.

A new report finds that brokers and agents say that carriers are incentivizing the sale of certain types of Medicare plans over others.

The battle over access to a key drug used for medication abortions heats up in a Texas courtroom, as Senators send a letter to Walgreens over its recent announcement that it will not dispense abortion pills in 20 states.

The pharmacy chain "deleted internal notes about suspicious prescribers" and allowed "millions of opioid pills" to flow illegally out of stores, alleges the Department of Justice.